Все публикации

0:04:29

Difference between Crossover & Parallel Study Design

0:05:50

FTF (First to File) Generic

0:07:22

Workflow In BA\BE Studies

0:07:42

Regulatory Criteria For BABE Studies (ABE & RSABE Approach)

0:10:32

How to decide Time Points in BA/BE Studies

0:06:31

80 to 125% Bioequivalence Criteria Comes from ?

0:03:25

Regulatory criteria on sample size for BA/BE Studies (Video.2)

0:14:07

Pharmacokinetics: General Consideration

0:08:05

ANDA (Abbreviated New Drug Application)

0:07:58

Bioavailability & Bioequivalence Studies ~ Introduction

0:04:25

CDSCO GCP V/s ICH GCP

0:04:28

Drug Development Process

0:05:52

Pharmacovigilance~ Anti Diabetic Drugs Classifications

0:03:03

Pharmacovigilance Companies

0:07:36

Study Designs ~ Clinical Trials

0:03:53

Biostatistics ~ Blinding

0:04:11

Biostatistics ~ Parametric & Non Parametric Test

0:04:22

Biostatistics ~ Statistical Errors

0:02:32

Biostatistics ~ Student ‘t’ test

0:02:24

LinkedIn Interview Preparation Feature

0:04:11

Adverse Drug Reaction Types (Pharmacovigilance)

0:07:00

GCP (13 Principles)

0:03:59

Regulatory Bodies (Pharmacovigilance, CDM, RA)

0:22:52

Argus (Pharmacovigilance)